British Society of Allergy and Clinical Immunology (BSACI) guideline – Prescribing an Adrenaline Auto-Injector
- 07 October 2016
- News
7th October 2016
Following the publication of the BSACI’s new guidance on Prescribing an Adrenaline Auto-Injector, we know that many of you are concerned about the number of AAIs the BSACI are recommending for patients. We are also aware that individuals are taking action to campaign against the guidance.
The Anaphylaxis Campaign position has always been that all patients prescribed adrenaline should have two AAIs on their person at all times.
This week our CEO, Lynne Regent, has been in discussions with the Medicines and Healthcare Products Regulatory Agency (MHRA) and with the BSACI on this important issue.
The MHRA have reiterated that “people with allergies and their carers should carry two adrenaline auto-injectors”. Their full information page is available here.
We will keep you updated as these discussions progress.
AAIs in schools campaign
We are also campaigning for spare adrenaline auto-injectors to be available in all schools as part of their medical first aid kits – as we feel this is very important for children affected by severe allergy. We have now presented to the MHRA via the Department of Health a detailed dossier of evidence and information and we are now awaiting their decision regarding next steps.
